10 popular drugs that saw list price increases in Q2

Below are 10 commonly prescribed drugs that increased in list price in the second quarter of 2019, according to GoodRx's latest quarterly report

1. Genvisc 850 costs $159.60 per 2.5 ml syringe  — a 135.1 percent increase 

2. Cotempla XR costs $12.36 per 17.3 mg tablet — an 8.4 percent increase

3. Nuedextra costs $19.57 per 20 mg/ 10mg tablet — a 6.9 percent increase

4. Abilify Maintena costs $2,274.73 for one 400 mg vial — a 5 percent increase

5. Isentress costs $26.24 per 400 mg tablet — a 5 percent increase

6. Cabometyx costs $639.73 per 60 mg tablet — a 4.5 percent increase

7. Xiidra costs $8.70 per 5 percent ampule — a 3 percent increase

8. Vyvanse costs $10.13 per 40 mg tablet — a 3 percent increase

9. Gattex costs $39,271.88 per 5 mg vial — a 3 percent increase

10. Firazyr costs $3,715.83 per 30 mg/3 ml syringe — a 3 percent increase

More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
New Jersey physician, pharmacy workers charged in $10M kickback scheme

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars